Almost every pitch deck has a slide with three concentric circles: a huge number on the outside, a smaller one in the middle, and a modest one at the centre. The labels are TAM, SAM and SOM. The slide is so common that it is easy to treat it as decoration. Done properly, though, it is one of the most useful pieces of thinking a revenue leader can do, because it forces a company to say where its growth will actually come from.

Three circles, three questions

Total Addressable Market (TAM) answers: if every possible customer bought this kind of product, how much revenue would that be in a year? It ignores competition, geography and your own limitations. It is a measure of how big the problem is.

Serviceable Available Market (SAM), sometimes called serviceable addressable market, answers: of that total, how much could our product, as it exists, actually serve? It applies real constraints: the regions you sell in, the languages you support, the customer sizes your product fits, the integrations you have built.

Serviceable Obtainable Market (SOM) answers: of the serviceable market, how much can we realistically win in a defined period, given competitors, our sales capacity and our brand? This is the number that should connect to a revenue plan.

A bottom-up example

Imagine a start-up selling lab management software to independent diagnostic laboratories in India, at ₹60,000 per lab per year.

Suppose the team estimates, from industry registrations and association data, that there are about 25,000 independent labs in the country. If every one bought the product, revenue would be 25,000 × ₹60,000 = ₹150 crore a year. That is the TAM.

The product currently works only in English and Hindi, needs reliable internet, and the company has support staff only in a handful of states. After filtering for these constraints, perhaps 40% of labs are realistically serviceable: 10,000 labs, or ₹60 crore. That is the SAM.

Now the hard question. Several established competitors exist, and many labs are content with spreadsheets. With four salespeople, each closing about four labs a month, the team could win around 576 labs in three years if nobody left and the pace held. Allowing for churn and slower months, a target of roughly 5% of the SAM, about 500 labs or ₹3 crore of annual revenue, is defensible. That is the SOM.

LayerLabsAnnual revenueKey constraint applied
TAM25,000₹150 croreNone
SAM10,000₹60 croreLanguage, connectivity, support coverage
SOM (3 years)about 500about ₹3 croreCompetition, sales capacity

Notice how far ₹3 crore is from ₹150 crore. That gap is not a weakness in the analysis; it is the analysis. It shows how much growth depends on expanding the SAM, through more languages, offline support or new states, rather than simply selling harder.

Top-down versus bottom-up

The example above is bottom-up: count the customers, multiply by what each would pay. The alternative, top-down sizing, starts with a published industry figure, such as “the Indian healthcare IT market is worth X”, and takes a percentage of it.

Top-down is quick and useful as a sanity check, but it is prone to a well-known trap: “if we get just 1% of this enormous market, we will be huge”. That reasoning skips every hard question about who the customers are, why they would choose you and how you would reach them. Investors and experienced leaders tend to distrust it for exactly that reason.

Bottom-up sizing is slower, but every number in it can be questioned and improved. How many labs are there? What would they really pay? How many can one salesperson close? When the top-down and bottom-up figures roughly agree, confidence rises. When they disagree wildly, one of them is wrong, and finding out which is valuable.

How revenue leaders use the layers

TAM is mostly a strategic and investor conversation. It tells you whether a market is large enough to build a substantial company in.

SAM shapes product and expansion decisions. If the SAM is small relative to TAM, the question is which constraint, if removed, would unlock the most. That might be a new geography, a new language, a lower-priced tier for smaller customers, or an integration with a widely used system. Comparing these options by the SAM each one adds is a disciplined way to choose between them.

SOM connects to the operating plan: headcount, quotas, marketing budgets. If the board wants ₹10 crore in three years and the SOM analysis supports ₹3 crore, someone needs to explain what will change: more salespeople, a partner channel, a bigger SAM, or a higher price.

Common mistakes

  • Counting adjacent markets as TAM. Including all healthcare software spend when you sell only lab software inflates the number without informing any decision.
  • Using list price for everyone. Real average prices after discounts and smaller plans are usually lower.
  • Ignoring the status quo. “Do nothing” is the biggest competitor in many markets. Customers using spreadsheets are in your TAM, but converting them is slow.
  • Treating SOM as a target pulled from the air. A SOM should be traceable to capacity and win rates, not reverse-engineered from the number leadership wants.
  • Never updating it. Markets shift. A sizing done two years ago, before a new regulation or a competitor’s price cut, may be badly out of date.

The three circles look simple. Their value comes from being honest about the steps between them.

Written by the RP Strativa Team. The company, lab counts and figures in the example are illustrative.

Leave a Reply

Trending